Holen Sie sich die Stockscreener-App
3.01
14.49%
-0.51
Handel nachbörslich:
3.05
0.04
+1.33%
Schlusskurs vom Vortag:
$3.52
Offen:
$3.46
24-Stunden-Volumen:
642.23K
Relative Volume:
1.51
Marktkapitalisierung:
$51.11M
Einnahmen:
$152.40K
Nettoeinkommen (Verlust:
$-10.52M
KGV:
-1.2073
EPS:
-2.4931
Netto-Cashflow:
$-4.26M
1W Leistung:
-15.69%
1M Leistung:
+63.59%
6M Leistung:
+478.85%
1J Leistung:
+255.12%
1-Tages-Spanne:
$2.95
$3.46
1-Wochen-Bereich:
$2.95
$3.92
52-Wochen-Spanne:
$0.40
$5.48
Abvc Biopharma Inc Stock (ABVC) Company Profile
Firmenname
Abvc Biopharma Inc
Sektor
Branche
Telefon
510-668-0881
Adresse
44370 OLD WARM SPRINGS BLVD., FREMONT
Vergleichen Sie ABVC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABVC
Abvc Biopharma Inc
|
3.01 | 60.62M | 152.40K | -10.52M | -4.26M | -2.4931 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Abvc Biopharma Inc Aktie (ABVC) Neueste Nachrichten
Is ABVC BioPharma Inc. a good long term investmentBreakthrough financial growth - jammulinksnews.com
What drives ABVC BioPharma Inc. stock pricePowerful growth strategies - jammulinksnews.com
What analysts say about ABVC BioPharma Inc. stockStrong return on assets - jammulinksnews.com
Is ABVC BioPharma Inc. stock a growth or value playAlpha Stock Ideas - Newser
ABVC BioPharma Inc. Stock Analysis and ForecastFree Advanced Stock Screener Access - jammulinksnews.com
What makes ABVC BioPharma Inc. stock attractive to long term investorsValue Pick Scanner - Newser
ABVC BioPharma Records $100,000 Licensing Milestone From ForSeeCon, Strengthening Eye Health Program - Yahoo Finance
What makes ABVC BioPharma Inc. stock price move sharplySteady Profit Stock Forecasts - Newser
Why ABVC BioPharma Inc. stock attracts strong analyst attentionDaily Gain Forecast - Newser
How ABVC BioPharma Inc. stock performs during market volatilityFree Exclusive Access to Stock Gurus - Newser
ABVC BioPharma Soars 16%—Is This the Breakout Biotech Investors Have Been Waiting For? - AInvest
ABVC BioPharma Receives $150K Milestone From AiBtl, Bringing Total Licensing Revenue to $846K Across Strategic Partnerships - Yahoo Finance
ABVC BioPharma CEO Dr. Uttam Patil Recognized Among Elite Indian-Origin CEOs Making Global Impact in Science and Technology - StreetInsider
ABVC BioPharma Converts Strategic Note Into Equity in AiBtl BioPharma; Commits to Up to $20 Million in Total Investment - Yahoo Finance
ABVC BioPharma's Affiliate OncoX Acquires Lycopenoid Platform to Strengthen Oncology Portfolio - citybuzz -
ABVC BioPharma Expands Oncology Portfolio as Affiliate OncoX Acquires Patented Lycopenoid Platform Valued at $4.06 Million - The Globe and Mail
ABVC BioPharma Shareholders Approve Key Proposals - TipRanks
ABVC BioPharma Announces Board Approval of Share Dividend Showing Confidence in Subsidiary Growth and Long-Term Shareholder Value - Yahoo Finance
ABVC BioPharma, Inc. (NASDAQ:ABVC) Short Interest Up 40.0% in May - Defense World
3 Top Growth Stocks to Buy in the Second Half of 2025 - The Globe and Mail
ABVC BioPharma Files $100 Million Mixed Shelf - marketscreener.com
ABVC BioPharma Regains Nasdaq Minimum Bid Price Compliance - Yahoo Finance
ABVC BioPharma Secures Japanese Patent for Botanical Depression Treatment - citybuzz -
ABVC BioPharma Secures Japanese Patent for Its Natural MDD Treatment Candidate ABV-1504 - Yahoo Finance
ABVC BioPharma Announces First Quarter 2025 Financial Results and Strategic Planning for AI-Driven Agricultural Project in Taiwan - Yahoo Finance
Finanzdaten der Abvc Biopharma Inc-Aktie (ABVC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):